Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001765581-22-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-05 | JAZZ | RIEDEL NORBERT G | Dir | M - OptEx | $55.28 | +8,000 | 18.4K | +77% | +$442.2K |
| DM | 2022-08-09 | 2022-08-05+ | JAZZ | RIEDEL NORBERT G | Dir | S - Sale+OE | $155.44 | -9,089 | 10.4K | -47% | -$1.41M |
| D | 2022-08-09 | 2022-08-05 | JAZZ | RIEDEL NORBERT G | Dir | A - Grant | $0.00 | +2,561 | 13.0K | +25% | $0 |
| D | 2022-08-09 | 2022-08-05 | JAZZ | RIEDEL NORBERT G | Dir | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-05 | M | A | 8,000 | $55.28 | 18,399 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-08-08 | S | D | 1,089 | $152.32 | 11,871 | D | — | — | |
| 3 | Common | Ordinary Shares | 2022-08-05 | A | A | 2,561 | $0.00 | 12,960 | D | — | — | |
| 4 | Common | Ordinary Shares | 2022-08-05 | S | D | 8,000 | $155.87 | 10,399 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.80.00 to $156.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-05 | M | D | 8,000 | $0.00 | 0 | D | $55.28 · — to 2023-05-08 | 8,000 Ordinary Shares | (F4) This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter. |